Venus Remedies files for patent on its research report

Venus Remedies Ltd has informed that the Company has successfully filed for Patent protection for its 4th Research Product, "Parenteral Combination Therapy for infective conditions with Drug Resistant Bacterium" in 48 countries across the globe, completing the National Phase of the 4th PCT well within the timeline.

The in-house Research and Development wing of the Company had developed this innovative remedy, a Fixed Dose Combination, as the only solution for treatment of Meningitis. The same was launched for the first time globally in Indian Market in October 2005 under Strategic Marketing Tie-ups with leading Indian MNCs, after filing for Indian Patent. The high-end niche product has fast penetrated the market for specialty formulations and grown to be an INR 250 million brand within 2 years of its launch.

The Company has selected 48 countries with high marketing potential for this product in a world market worth USD 900 million, including Australia, Brazil, Canada, China, E.U, New Zealand and USA, being major ones amongst the total.